NL-OMON35195招募中4 期
Comparison of the everolimus eluting XIENCE-V* stent with the paclitaxel eluting TAXUS* stent in all-comers: a randomized open label study. - MCRZ-COMPARE
Medisch Centrum Rijnmond-Zuid0 个研究点目标入组 1,600 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 1,600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •All patients referred for PCI according to dutch and european guidelines
- •Age between 18-85 years
排除标准
- •1 Expected non-adherence to dual antiplatelet therapy for 1 year (e.g: known allergy to ASA or thienopyridines like clopidogrel)
- •2 Expected major surgery within 30 days (these patients will receive bare metal stents)
- •3 Expected loss for follow up
- •4 Enrollment in another stent study with different stents
- •5 Inability to implant Taxus or Xience-V stent(s)
研究者
相似试验
招募中
4 期
Comparison of the everolimus eluting (XIENCE-V*/XIENCE-PRIME* or PROMUS* stent) with the biolimus A9 eluting NOBORI* stent in all-comers: a randomized open label study.outcome PCI treatment with stents10011082NL-OMON35434Overige Ziekenhuizen2,000
已完成
不适用
A Clinical Evaluation of the XIENCE TM V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Coronary Artery Lesionscoronary artery lesions10003216NL-OMON29915Abbott225
Unknown
4 期
COMPARE-II- Vasomotion and Imaging SubstudyCoronary Artery DiseaseNCT01329237University of Freiburg50
尚未招募
不适用
Comparison of everolimus eluing stent and zorarolimus eluting stent in long coronary artery lesioDiseases of the circulatory systemKCT0000208Pusan National University Yangsan Hospital600
已完成
4 期
Comparison of the ABSORB TM Everolimus Eluting Bioresorbable Vascular Scaffold System With a Drug- Eluting Metal Stent (XienceTM) in Acute ST-Elevation Myocardial InfarctioInfarction due to closure of coronary arteries with ECG changes.ST Elevation Myocardial Infarction10028593NL-OMON40503ECRI B.V.64